CEPHRADINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cephradine, and when can generic versions of Cephradine launch?
Cephradine is a drug marketed by Barr, Ivax Sub Teva Pharms, Teva, and Vitarine. and is included in eight NDAs.
The generic ingredient in CEPHRADINE is cephradine. There are ten drug master file entries for this compound. Additional details are available on the cephradine profile page.
Summary for CEPHRADINE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Patent Applications: | 4,820 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEPHRADINE at DailyMed |
Medical Subject Heading (MeSH) Categories for CEPHRADINE
US Patents and Regulatory Information for CEPHRADINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Barr | CEPHRADINE | cephradine | CAPSULE;ORAL | 062850-001 | Apr 22, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vitarine | CEPHRADINE | cephradine | CAPSULE;ORAL | 062813-001 | Feb 25, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ivax Sub Teva Pharms | CEPHRADINE | cephradine | CAPSULE;ORAL | 062762-002 | Mar 6, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |